| PACKAGING TYPE: | 10ml C-box |
| COMPOSITION: | Teicoplanin (200mg) |
| FORMULATION: | Injection |
| Description: | TARGOSAFE 200 Injection contains Teicoplanin 200 mg, a glycopeptide antibiotic used for the treatment of serious gram-positive bacterial infections. It works by inhibiting bacterial cell wall synthesis, leading to bacterial cell death. Teicoplanin is particularly effective against resistant organisms such as MRSA (Methicillin-resistant Staphylococcus aureus) and is widely used in hospital and ICU settings. It is commonly prescribed for skin and soft tissue infections, respiratory infections, bone and joint infections, septicemia, and endocarditis. |
| Side Effects: | Injection site reactions Fever or chills Rash or hypersensitivity reactions Rare nephrotoxicity Rare hearing disturbances |
| How to Use: | To be administered by healthcare professionals only Given via IV or IM route as prescribed Loading dose followed by maintenance dosing Dosage based on infection severity and patient condition |
| Precaution: | For hospital use only Monitor kidney function during therapy Use cautiously in patients with renal impairment Monitor for allergic reactions Not for self-administration |
| Product Benefits: | Strong activity against gram-positive bacteria Effective against MRSA and resistant strains Long half-life allows less frequent dosing Suitable for severe and hospital-acquired infections Lower nephrotoxicity compared to some alternatives Ideal for I |
Frequently Asked Questions
It is used for serious gram-positive infections including MRSA.
Yes, it is used for resistant and severe infections.
Yes, especially kidney function during prolonged use.










